Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Abroad (travel likely)RecruitingPHASE3

Conditions

Graves Ophthalmopathy · Thyroid Associated Ophthalmopathy · Thyroid Associated Orbitopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dpt. of Endocrinology, SUS Malmö, Malmö, Sweden
Contact: Study coordinator (Tereza Planck, MD, PhD) · tereza.planck@med.lu.se

Study leads

Tereza Planck, MD, PhD
Principal Investigator
Lund University and Skåne University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Thyroid Eye Disease · Graves Orbitopathy · Endocrine System Diseases

Abroad (travel likely)RecruitingPHASE2, PHASE3

Miami, United States · Morgantown, United States

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Thyroid Associated Ophthalmopathy

Abroad (travel likely)RecruitingPHASE3

Bangkok Noi, Thailand

Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy

Abroad (travel likely)Recruiting

Taipei, Taiwan

Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease

Graves Disease · Graves Ophthalmopathy

Abroad (travel likely)Recruiting

Elâzığ, Turkey (Türkiye)